Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy
- Resource Type
- Article
- Source
- In
The Journal of Allergy and Clinical Immunology: In Practice July 2023 11(7):2208-2216 - Subject
- Language
- ISSN
- 2213-2198